SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-040769
Filing Date
2009-02-27
Accepted
2009-02-27 14:49:37
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1452848
2 GILEAD SCIENCES, INC. 2005 DEFERRED COMPENSATION PLAN dex1026.htm EX-10.26 142828
3 GILEAD SCIENCES, INC. SEVERANCE PLAN dex1027.htm EX-10.27 225389
4 ADDENDUM TO TENOFOVIR DISOPROXIL FUMARATE MAN. SUPPLY AGREEMENT dex1053.htm EX-10.53 62744
5 PURCHASE AND SALE AGREEMENT AND ESCROW INSTRUCTIONS dex1057.htm EX-10.57 150066
6 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 13660
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2518
8 CERTIFICATION OF CEO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 6371
9 CERTIFICATION OF CFO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 6390
10 CERTIFICATIONS OF CEO AND CFO, AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4921
11 GRAPHIC g20802g68p70.jpg GRAPHIC 84037
  Complete submission text file 0001193125-09-040769.txt   2185065
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19731 | Film No.: 09642016
SIC: 2836 Biological Products, (No Diagnostic Substances)